American International Holdings Deck March 2022

Investor Presentation
March 2022
Telemedicine
Preventative & Wellness
Health Technology & Infrastructure
Online Digital Pharmacy
AMIH
AMERICAN INTERNATIONAL HOLDINGS CORP

SAFE HARBOR & FORWARD-
LOOKING STATEMENTS
This presentation contains, and our officers may make, “forward-looking” statements that are based on out management’s beliefs and assumptions and
on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or
assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as
“anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,”
and other similar expressions.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or
achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.
These statements are based on certain assumptions that we have made in light of our experience in the industry and our perception of historical trends,
current conditions, expected future developments, and other factors we believe are appropriate under the circumstances as of the date hereof. These
and other important factors may cause our actual results, performance, or achievements to differ materially from those expressed or implied by these
forward-looking statements. Such risks and other factors that may impact management’s beliefs and assumptions are more particularly described in our
filings with the U.S. Securities and Exchange Commission (the “SEC”),in our Annual Report on Form 10-K for the year ended December 31, 2020, and
under similar headings in our subsequently filed Quarterly Reports on Form 10-Q and could cause our results to differ materially from those expressed in
forward-looking statements. As a result, we cannot guarantee future results, outcomes, levels of activity, performance, developments, or achievements,
and there can be no assurance that our expectations, intentions, anticipations, beliefs, or projections will result or be achieved or accomplished. The
forward-looking statements in this presentation are made only as of the date hereof. Except as required by law, we assume no obligation to update these
forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even
if new information becomes available in the future.
This presentation contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data
about our industry. This data involves several assumptions and limitations, and you are cautioned not to give undue weight to such estimates.
AMIH

Investing in the Advancement of Humanity
Vision
Build a portfolio of synergistic -- primarily digitally based -- health and wellness businesses serving the millions
of Americans lacking affordable primary medical/mental health & wellness support and services.
Portfolio companies were conceived and built to be scalable digital based – not a digital extension of sprawling
brick & mortar HMOs trying to lower cost of delivery to its fully insured members
Objectives
§ Bring to market disruptive services and technologies that create positive change in the industry, for small
business employers, and the un- and under-insured masses.
§ Bridge the gap between Primary Medical and Mental Health and Preventative Care and Wellness services
for 82 million Americans, many working and middleclass -- without affordable access.
§ Create out-sized shareholder value via an exponentially scalable portfolio – with high gross margins -- that
is pandemic and recession defensive and provides limitless growth potential.
CORE VISION & OBJECTIVES
AMIH
4

ABOUT AMIH
AMIH
5
AMIH is a diversified holding company that develops, acquires and operates technology-based health
and wellness companies.
Its growing portfolio encompasses:
§ Telemedicine and other virtual health platforms
§ Subscriber-based primary care and concierge medicine plans
§ Preventative care solutions
§ Wellness related assets such as preventative and nutritional counseling, proprietary nutrition-based
products, mental & behavioral health services (stress, anxiety, substance abuse, depression)
§ Proprietary life-coaching platform: career, well-being, executive, personal & transformational
§ Online digital mail order pharmacy with intent to be licensed and accredited in all 50 states
§ Telemedicine platform marketing and selling branded pharmaceutical men's health and wellness
products
AMIH provides affordable services through direct-to-consumer (D2C) and B2B distribution channels.

Common Stock Synopsis As of March 15, 2022
Total Authorized 195,000,000
Total Issued & Outstanding 95,797,773
Distribution
Restricted 17,743,849 / 18.52%
Mngt / D&O 33,000,000 / 34.45%
Float 45,053,924 / 47.03%
Preferred Stock Synopsis
Total Authorized 5,000,000
Series A - Super Majority
Voting Rights
1 (one)
Series B - Financing
Instrument Purposes
2,000,000 Authorized
-0- Outstanding
AMIH
6
CAP STRUCTURE HIGHLIGHTS
AMIH 1-year price chart

HISTORICAL OVERVIEW
2020 2021
2019
AMIH
Point
of
Demarcation
Successfully responded to pandemic
with business model pivot from Med
Spas to Telemedicine and online
health and wellness companies à

INVESTMENT HIGHLIGHTS
AMIH
I N V E S T M E N T H I G H L I G H T S
§ Seasoned, Proven Entrepreneurial Management Team
§ Digitally Focused, Capital Efficient, Highly Scalable, D2C and B2B Marketing Models
§ Competitive Advantages: Conceived and created in the Digital (low-cost) New Normal, serves an
ecommerce-oriented marketplace and consumer base
§ $194 Billion TAM: One-in-four US adults lacking affordable primary care and their employers
§ Synergistic Portfolio, Numerous Cross-Marketing Opportunities
§ Public Company, Lower Cost of Capital (Company has retained Maxim Group, a mid-tier investment
bank, for a firm commitment capital raise later this year when market conditions are optimal)
§ Subscription Based Model, Recurring Revenue
https://www.physiciansweekly.com/declining-numbers-of-americans/
https://creakyjoints.org/doctor-patient/americans-with-primary-care-doctor-declining/#:~:text=For%20a%20growing%20number%20of,part%20of%20a%20declining%20trend venues
8

AMIH
PORTFOLIO STRATEGY &
SYNERGIES
Core Ideology
§ Making Primary Medical and Mental Telehealthcare, prescriptions/labs, affordable for the masses
§ Bridging the gap from uninsured and under-insured – to Primary Care, Preventive Care & Wellness
§ Primary Care market in 2020 is $296 billion; forecasted to grow to $409 billion in 2027
§ Due to increase in chronic diseases, the Preventive Care market is expected to reach $432 billion in 2024
§ Forbes: the “Wellness Economy” is valued at over $4.2 trillion and expected to boom over next ten years
§ Integrated technology platform – decentralized health network; 21st century healthcare
10

VALUE PROPOSITION
AMIH
11
The AMIH Value Proposition
Shareholders Entrepreneurs Marketplace
Essential Products & Services
Pandemic & Recession Defensive
Recurrent Revenue Model
Global Expansion Plans
Multiple Levers for Growth
Acceleration & Strategy Assistance
Growth & Expansion Opportunities
Support & Mentorship
Access to Working Capital
Portfolio Value-Added Synergies
Affordable Healthcare Solutions
Effective & Innovative Products
Preventative Care
Wellness Programs
Quality of Life Improvement

&
The Next Generation of TeleWellness
AMIH
13
Who are the Un- and Under-Insured?
ZipDoctor’s low-cost, subscription telemedicine proof-of-concept led to EPIQ MD – both have defined their markets and are now
operational.
EPIQ MD, Inc., AMIH’s flagship entity, and ZipDoctor indirectly, address 82 million uninsured or under-insured US residents falling
through a massive primary care gap: 43.4 percent of US adults ages 19 to 64 lacking access to primary care are middle class,
ineligible for overburdened sub-poverty line state services. Healthcare costs have outpaced working wages and U.S. GDP by
177% the past decade.
Technically, many of these families have medical insurance, but they and/or their employers can only afford the far cheaper major
medical policies that typically carry a deductible of $10,000 or more covering catastrophic illness. This leaves many workers
having to go out of pocket at insurance company rates for primary care to cover minor illness and injuries, or vital preventative
care.
Industry experts say half of all working Americans decline the insurance offered by their employer as they are forced to choose
between insurance or putting food on the table. AMIH research shows that small businesses in particular would like to provide
primary care services -- not merely major medical -- if they could afford it. These 82 million uninsured and inadequately insured US
adults and their employers are AMIH’s target market; it’s big and we believe it is demand driven.
https://www.pbs.org/healthcarecrisis/uninsured.html
https://www.forbes.com/sites/brucejapsen/2019/09/12/in-2020-employer-health-costs-to-double-inflation-rate-yet-again/?sh=1563eb6a2754
https://www.cbsnews.com/news/minimum-wage-2019-almost-half-of-all-americans-work-in-low-wage-jobs/
https://www.healthsystemtracker.org/chart-collection/u-s-spending-healthcare-changed-time/#item-usspendingovertime_4
https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/
https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/
https://www.commonwealthfund.org/press-release/2019/underinsured-rate-rose-2014-2018-greatest-growth-among-people-employer-health

AMIH
14
The Facts About Uninsured, and Underinsured Health Care Coverage
According to the Kaiser Family Foundation Nov. 6, 2020, report:
• Most uninsured people have at least one worker in the family.
• Most of the nonelderly in the U.S. obtain health insurance through an employer, but not all workers are offered employer-sponsored coverage
or, if offered, can afford their share of the premiums.
• Cost still poses a major barrier to coverage for the uninsured. In 2019, 73.7% of uninsured nonelderly adults said they were uninsured because
coverage is not affordable.
• In 2019, a quarter of uninsured nonelderly adults said they were uninsured because they were not eligible for coverage.
• In 2019, 72.5% of nonelderly uninsured workers worked for an employer that did not offer them health benefits.4 Among uninsured workers who
are offered coverage by their employers, cost is often a barrier to taking up the offer.
The 2020 Commonwealth Fund Biennial US Health Insurance Survey, 2020 reports: In the first half of 2020, 43.4% of adults were inadequately insured.
This group is made up of uninsured (12.5%), insured but had a coverage gap (9.5%), or insured continuously but had such high out-of-pocket costs or
deductibles relative to their income that they were effectively underinsured (21.3%).
That report adds, more than one-third (35%) of all adults reported at least one cost-related problem getting needed health care in the past year
including not filling a prescription; skipping a recommended test, treatment or follow-up visit; not going to a doctor when sick.
“One-quarter of adults in employer plans are underinsured;” and the “Share of privately insured adults with deductibles of $1,000 or more has
doubled since 2010. In 2010, only 7% of people in private plans had deductibles that amounted to 5 percent or more of income. By 2016, that share
was 15 percent.”

Portfolio Entity
✓ ✓ ✓ ✓ ✓
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
✓ ✓ ✓ ✓ ✓ ✓
✓ ✓ ✓ ✓ ✓ ✓ ✓
✓ ✓ ✓ ✓ ✓ ✓
Primary
Care
Global
Expansion
Proprietary
Ingestible(s)
Technology
&
Infrastructure
Health
&
Wellness
Preventative
Care
B2B/Industry
Based
Consumer
Based
Pandemic
or
Humanitarian
Relief
AMIH
Chronic
Diseases
PORTFOLIO SYNERGIES

FACT SHEET
Live a life you love. LifeGuru was created by a team of life coaches and
professionals committed to helping people across the
globe live a life they love. LifeGuru provides the best
resources, anytime anywhere and understands the life-
changing impact that coaching can have. A billion-dollar
industry, LifeGuru is designed to make these services far
more accessible and affordable via tele-video than ever
before.
LifeGuru is the largest platform of the world’s best
coaches. Whether you want career coaching, a business or
leadership coach, to improve your health & wellbeing, or
you want to work with a personal life coach or
transformational coach; finding the perfect coach has
never been easier. It is a life enriching resources hub
helping people across the globe achieve their goals and
create success.
• Largest global directory of life coaches
• $991 MM life coaching addressable market value
• Proprietary Software Platform
• Repeat Order Factor (compounding revenue)
• Pandemic fatigue fueled life coaching and
therapy movement
• Businessmen and women
• Business owners
• Corporate Clients & Sales Organizations
• Those interested in health and wellness
• Those seeking changes in their life (i.e. health,
dating, career, personal development etc.)
Highlights
Key Customers
16
Services
• Life coaching
• Mentoring and guidance
• Resource hub with access to webinars, libraries and
coaching related articles
• Career coaching
• Health and wellbeing (nutritional) coaching
• Personal transformational coaching

17
Because everyone deserves to live an Epiq life.
• Innovative 3-in-1 Platform
• $4.5 Trillion Global Market
• Affordable Pricing for the Masses
• Proprietary Customer Experience
• Expansion: Limited Insurance Products
• International Expansion Capabilities
• Strong Management & Board
• LatinX & African-American
Communities
• Uninsured & Underinsured
• Blue-Collar Working Class, Middle
I& Upper-Middle Income
• Single Parents
• Students
• Service Industry
• Commercial & Municipalities
Market Opportunity Highlights
FACT SHEET
• Telemedicine & Virtual Doctor Primary & Wellness Care
• Telewellness Mental Health Therapy (anxiety,
depression, substance abuse)
• Prescription Discount & Fulfillment
• Proprietary Nutrition & Supplements (Epiq Innovations)
• Diet & Nutrition Planning and Medical Advisory
• Lab Diagnostics (Preventive Care) coming soon
• Chronic Disease Management 2022
Services
EPIQ MD is the convergence of Primary Care,
Preventive Care and Wellness Programs - on one
platform with 24/7/365 access. We exist to bring
these services to the uninsured and underinsured
82 million Americans.
EPIQ MD launched its operations on August 31, 2021
in 3 States with plans to scale up to all 50 States by
mid 2022.

FACT SHEET
18
Access to a Doctor in a Zip!
ZipDoctor, Inc. operates www.ZipDoctor.co, which was originally created to
provide customers with 24/7 access to a primary care and mental health
provider on a subscription basis for one low recurring monthly payment.
Since the launch of EPIQ MD, ZipDoctor has shifted its business model to
provide customized telehealth solutions for various healthcare businesses
seeking a more efficient solution to connect with their current and future
customers/clientele.
It is with this approach that ZipDoctor intends to market to various
healthcare providers to develop a customized telemedicine solution and a
centralized technology platform to collect and manage patient
demographics, insurance information, and collect acute health information
for the purpose of being reviewed for treatment by ZipDoctor’s network of
providers.
• Launched Telemedicine Platform and ZipDoctor website in August, 2020
• Contracted with a network of primary care doctors across the United States
• Utilized Digital and Social Media Marketing as initial proof of concept
• Scalable solution with marketability to additional pharmacies nationwide
• Specialty Pharmacies
• Specialty Healthcare Providers
• Diagnostic Laboratories
• Surgery Centers
• Other Ancillary Healthcare Providers
Highlights
Market Opportunity

FACT SHEET
19
Online Digital Mail Order Pharmacy
EPIQ Scripts, LLC has been established with the intent of operating as a
close-door online mail order pharmacy with a specific target and vision to
obtain licenses in all 50 states across the U.S. Led by pharmacy and
healthcare industry veterans, EPIQ Scripts also plans to seek to become
accredited with the most respected and highly recognized authorities in the
industry, such as URAC, Legit Script, ACHC and NABP Digital Pharmacy.
EPIQ Scripts also intends to obtain in-network contracts with all major
Pharmacy Benefit Managers (PBM) and insurance payors.
EPIQ Scripts will market itself to the many up and coming telemedicine
companies that have been on the rise since early 2020. The significant
increases in demand for telemedicine has created a vacuum for pharmacies
that have the capabilities to handle the prescription volume generated by
these platforms. EPIQ Scripts believes that with its advanced API capabilities,
infrastructure and nationwide licenses and accreditations, it will be able to
position itself to capitalize on the current market opportunity.
• Established in January, 2022
• Applied for national accreditation with Utilization Review and Accreditation Commission (URAC)
• Partnered with pharmacy and healthcare experts, Sultan Haroon and Maja Matthews, with a combined 40+
years of experience in building and operating pharmacies with nationwide licenses and accreditations
• Scalable solution with marketability to telemedicine companies
• Plans to be licensed in all 50 states across the U.S. by end of 2022
• Telemedicine Companies
• Specialty / Branded Pharmaceutical
Products
• Diagnostic Laboratories
• Surgery Centers
• Other Ancillary Healthcare Providers
Highlights
Market Opportunity

FACT SHEET
20
Men’s Health and Wellness Products
Mangoceuticals, Inc. has been established with the intent of focusing on
developing, marketing and selling a variety of men’s wellness products and services
via a telemedicine platform. To date, the Company has identified men’s wellness
telemedicine services and products as a growing sector and especially related to
the areas of erectile dysfunction and hair loss products. In this regard,
Mangoceuticals is currently in the process of developing and preparing to market a
new brand of erectile dysfunction (ED) products that delivers fast acting results
through a proprietary combination of FDA approved ingredients.
Mangoceuticals plans to market and sell this new brand of ED products exclusively
online and will require the use of a telemedicine visit, a doctor’s prescription and
the fulfillment of the prescription by EPIQ Scripts. Mangoceuticals plans to rely
heavily on digital and social media marketing through channels such as Facebook,
Instagram, Twitter, Snap Chat and TikTok and further has plans to use digital
marketing with the goal of creating viral marketing campaigns, using social media
influencers and celebrities.
• Established in October 2021
• Identified 3rd party doctor's network and telemedicine technology provider
• Utilizing full-service marketing agency for web and brand development and
social media advertising efforts
• EPIQ Scripts to serve as digital online pharmacy to fulfill and dispense
branded pharmaceutical products
• Plans to market and sell in all 50 states across the U.S. by end of 2022
• Direct to Consumer
• Men’s Health and Wellness Sector
• Erectile Dysfunction, Hair Loss and
Weight Loss
• Mood enhancement and overall
performance
Highlights
Market Opportunity

INDUSTRY & MARKET DATA
$639 BILLION
Generated in
wellness industry
$4.5 TRILLION
Total industry
valuation
Global Wellness Institute
AMIH
22

Globally, approximately 1 in 3 of all
adults suffer from multiple chronic
conditions (MCCs)
-NCBI
Six in ten Americans live with at
least one chronic disease, like heart
disease and stroke, cancer, or
diabetes.
- CDC
0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50%
Heart Disease
Kidney Disease
High Cholesterol
Arthritis
COPD
Diabetes
Auto-immune
Percentage of Americans
Percentage of Americans
AMIH
23

The global nutraceutical market size was estimated
at $382.5 billion in 2019 --
and is expected to reach $412.7 billion in 2020.
Grand View Research
North American Nutraceuticals Market was valued
at 88.3 billion in 2020 --
and is estimated to reach $188.73 billion by 2025.
Market Data Forecast
AMIH
24

The global behavioral/mental
healthcare software & services market
size was estimated at $2.1 billion in 2019
and is expected to reach $2.3 billion
in 2020.
per – Grand View Research
USD
2.31
BILLION
USD
1.15
BILLION
2017 2022
USD
5.0
BILLION
2027
AMIH
25

AMIH 2021: The Breakout Year
26

2021 MID-YEAR ACHIEVEMENTS
AMIH
27
Since the Start of 2021, AMIH:
§ Reported over $5.7 million in 2020 gross consolidated revenue.
§ Closed nearly $4 million in institutional financing, strengthening AMIH’s financial position.
§ Appointed original “Shark Tank” Shark, iconic businessman Kevin Harrington, as inaugural Advisory Board Member -- one of the
most accomplished, prolific and best-connected entrepreneurs of our generation.
§ Acquired controlling interest of, and launched, LifeGuru.me; Named industry veteran Jane Sorrell CEO.
§ Completed LifeGuru website, pivoted to life coach recruitment.
§ Pivoted ZipDoctor to a strategic niche B2B business model.
§ Appointed highly credentialed entrepreneur and marketing pro Alejandro “Alex” Rodriquez as EPIQ MD CEO.
§ Assembled an impressive EPIQ MD management team which continues to grow.
§ Launched EPIQ MD and EPIQ SCRIPTS
§ Developing Mangoceuticals and initial ED branded product for mid 2022 launch
§ Upgraded IR: Produced Investor web tab and Corporate Video; Retained 2 Senior IR Consultants.
§ Executed $10 Million firm commitment capital engagement with Maxim Group in connection with an uplisting to a listed
exchange (NYSE MKT or NASDAQ).

2H-21: MONETIZATION &
CASH FLOW
AMIH
28
AMIH Goals for the 2022
AMIH has spent all of 2021 working diligently, quietly, building what it believes is a solid corporate and operational foundation capable of
scaling its portfolio companies to exceedingly high levels of operations.
EPIQ MD: Launched in August 2021 and is planned to cover about half the US population by year end, to reach full national coverage by
end of 2022. Numerous ancillary products and services will be added incrementally along the way.
EPIQ Scripts: Launched early in 2022 as an online digital pharmacy to both service and support EPIQ MD and Mangoceuticals, as well as
to market to the many telemedicine companies that have been on the rise since early 2020. URAC accreditation in process and goal to
have majority of 50 state licenses by end of 2022.
Mangoceuticals: Launched quietly in end of 2021 with intent to focus on developing, marketing and selling a variety of men’s wellness
products and services via a telemedicine platform. Seeking to officially launch its initial proprietary ED branded product in May 2022 with
a soft launch in Texas and expanding to additional states at the same pace that Epiq Scripts obtains its licenses.
LifeGuru: With website complete, currently on-boarding life coaching professionals with a variety of specializations and in various global
regions. When the optimal number of coaches have joined, it will commence a series of multi-faceted marketing campaigns to attract
consumers.
Growth Capital. Confident in our outlook, in Q2-21 we retained renowned investment bank, Maxim Group, who has provided AMIH with a
$10 Million firm commitment capital raise in connection with an uplisting to a listed exchange (NYSE MKT or NASDAQ).

INVESTMENT HIGHLIGHTS
AMIH
I N V E S T M E N T H I G H L I G H T S
§ Seasoned, Proven Entrepreneurial Management Team
§ Digitally Focused, Capital Efficient, Highly Scalable, D2C and B2B Marketing Models
§ Competitive Advantages: Conceived and created in the Digital (low-cost) New Normal, serves an
ecommerce-oriented marketplace and consumer base
§ $194 Billion TAM: One-in-four US adults lacking affordable primary care and their employers
§ Synergistic Portfolio, Numerous Cross-Marketing Opportunities
§ Public Company, Lower Cost of Capital (Company has retained Maxim Group, a mid-tier investment
bank, for a firm commitment capital raise later this year when market conditions are optimal)
§ Subscription Based Model, Recurring Revenue
https://www.physiciansweekly.com/declining-numbers-of-americans/
https://creakyjoints.org/doctor-patient/americans-with-primary-care-doctor-declining/#:~:text=For%20a%20growing%20number%20of,part%20of%20a%20declining%20trend venues
29

APPENDIX
AMIH
30

“The global telemedicine market has
increased at a compound annual
growth rate (CAGR)
of 22.5% since 2015.”
AMIH
31
Source: The Business Research
Company

$49.89
BILLION $17.90
BILLION
43% of total
Global Telemedicine
Market (2019)
North American
Telemedicine Market (2019)
The market is expected to grow from
$49.89 billion in 2019 to $194.05
billion in 2023 at a remarkable rate
of 40.4%.”
Source: The Business Research Company
North America is expected to maintain
a steady incline through 2025, if not
surpass it due to COVID-19. – per Fortune
Business Insights
AMIH
32

§ The economic consequences of
the pandemic have made it
more difficult for the US to
afford the growing health care
costs that result from chronic
disease.
§ Important preventative tests
have fallen 81%, leading to a
gap in detection, prevention,
and education.
§ The rise in highly preventable
risk factors have left populations
vulnerable to health
emergencies such as COVID-19.
1 in 5 citizens
at increased risk
of COVID due to
underlying
conditions
90%
healthcare
spending
towards
treatment of
chronic disease
NCBI
Preventative
testing has
fallen 81%
The Lancet
AMIH
33

AMIH
VALUATION COMPS &
METRICS
Ticker
Company
Name
FYE PPS Market Cap Cash Total Debt
EPS
Multiple FY
EPS
Multiple
LTM
TDOC
Teladoc
Health, Inc.
12/31/2020 $194.49 29.68B 786.57MM 1.49B 16.2x 10.2x
GDRX GoodRX 12/31/2020 $40.46 17.42B 1.08B 733.37MM 17.3x -
HLF Herbalife 12/31/2020 $45.61 5.378B 1.05B 2.67B 8.4x 9.3x
NVTA Invitae Corp. 12/31/2020 $36.33 7.68B 353.98MM 450.14MM 14.4x 7.7x
ONEM
1Life (One
Medical)
12/31/2020 $41.74 5.56B 683.00 MM 412.21MM 10.4x 11.1x
JNJ
Johnson &
Johnson
1/3/2021 $152.08 410.65B 25.19B 36.37B 4.5x 4.8x
HIMS
Hims & Hers
Health, Inc.
12/31/2021 $5.15 $1.03B 71.7MM 49.53MM - -
34

RISK FACTORS
Since we have a limited operating history, it is difficult for potential investors to evaluate our business. Our short operating history in the health and wellness industry, construction industry and mentoring/life coach industry may hinder our ability to
successfully meet our objectives and makes it difficult for potential investors to evaluate our business or prospective operations. As an early-stage company, we are subject to all the risks inherent in the financing, expenditures, operations, complications
and delays inherent in a new business. Accordingly, our business and success face risks from uncertainties faced by developing companies in a competitive environment. There can be no assurance that our efforts will be successful or that we will ultimately
be able to attain profitability. We may not be able to raise capital when needed, if at all, which would force us to delay, reduce or eliminate our service locations and product development programs or commercialization efforts and could cause our business
to fail. We expect to need substantial additional funding to pursue additional service locations and product development and commercialize our products and services. There are no assurances that future funding will be available on favorable terms or at
all. The failure to fund our operating and capital requirements could have a material adverse effect on our business, financial condition and results of operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to
delay, reduce or eliminate our expansion of spa locations and development programs or any future commercialization efforts. Any of these events could significantly harm our business, financial condition and prospects. Our business has been materially
and adversely disrupted by COVID-19, and the control response measures that state and local governments have implemented to address it and may be impacted by other epidemics or pandemics in the future. An epidemic, pandemic or similar serious
public health issue, and the measures undertaken by governmental authorities to address it, could significantly disrupt or prevent us from operating our business in the ordinary course for an extended period, and thereby, and/or along with any associated
economic and/or social instability or distress, have a material adverse impact on our consolidated financial statements. On March 11, 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic and recommended
containment and mitigation measures. On March 13, 2020, the United States declared a national emergency concerning the outbreak, and several states and municipalities have declared public health emergencies. Along with these declarations, there
have been extraordinary and wide-ranging actions taken by international, federal, state and local public health and governmental authorities to contain and combat the outbreak and spread of COVID-19 in regions across the United States and the world,
including quarantines, “stay-at-home” orders and similar mandates for many individuals to substantially restrict daily activities and for many businesses to curtail or cease normal operations.
We may have difficulty obtaining future funding sources, if needed, and we may have to accept terms that would adversely affect stockholders. We will need to raise funds from additional financing in the future to complete our business plan and may need
to raise additional funding in the future to support our operations. We have no commitments for any financing and any financing commitments may result in dilution to our existing stockholders. We may have difficulty obtaining additional funding, and we
may have to accept terms that would adversely affect our stockholders. For example, the terms of any future financings may impose restrictions on our right to declare dividends or on the way we conduct our business. Additionally, we may raise funding by
issuing additional convertible notes, which if converted into shares of our common stock would dilute our then stockholders’ interests. Lending institutions or private investors may impose restrictions on a future decision by us to make capital expenditures,
acquisitions or significant asset sales. If we are unable to raise additional funds, we may be forced to curtail or abandon our business plan. If we make any acquisitions, they may disrupt or have a negative impact on our business. If we make acquisitions in
the future, funding permitting, which may not be available on favorable terms, if at all. We do not anticipate that any acquisitions or mergers we may enter in the future would result in a change of control of the Company. In addition, the key personnel of
the acquired business may not be willing to work for us. We cannot predict the effect expansion may have on business.
We engage in transactions with related parties and such transactions present possible conflicts of interest that could have an adverse effect on us. We have entered, and may continue to enter, into transactions with related parties for financing, corporate,
business development and operational services, as detailed herein. Such transactions may not have been entered into on an arm’s-length basis, and we may have achieved more or less favorable terms because such transactions were entered into with our
related parties. This could have a material effect on our business, results of operations and financial condition. Such conflicts could cause an individual in our management to seek to advance his or her economic interests or the economic interests of certain
related parties above ours. Further, the appearance of conflicts of interest created by related party transactions could impair the confidence of our investors. Such conflicts of interest will likely be greater until such time as we are able to appoint new
directors, as we currently have only one member of our board of directors, Jacob D. Cohen. Our business could be adversely affected by ongoing legal challenges to our business model or by new state actions restricting our ability to provide the full range
of our services in certain states. Our wellness business entails the risk of medical liability claims. Successful medical liability claims could result in substantial damage awards that exceed the limits of our insurance coverage. Any claims made against us that
are not fully covered by insurance could be costly to defend against, result in substantial damage awards against us and divert the attention of our management and our physicians from our operations, which could have a material adverse effect on our
business, financial condition and results of operations. In addition, any claims may adversely affect our business or reputation.
Our use and disclosure of personally identifiable information, including health information, is subject to federal and state privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold
could result in significant liability or reputational harm and, in turn, a material adverse effect on our client base and revenue. Numerous state and federal laws and regulations govern the collection, dissemination, use, privacy, confidentiality, security,
availability and integrity of personally identifiable information, or PII, including protected health information, or PHI. These laws and regulations include the Health Information Portability and Accountability Act of 1996, as amended by the Health
Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations (referred to collectively as HIPAA). HIPAA establishes a set of basic national privacy and security standards for the protection of PHI. HIPAA
requires us to develop and maintain policies and procedures with respect to PHI that is used or disclosed, including the adoption of administrative, physical and technical safeguards to protect such information. HIPAA imposes mandatory penalties for
certain violations. Penalties for violations of HIPAA and its implementing regulations start at $100 per violation and are not to exceed $50,000 per violation, subject to a cap of $1.5 million for violations of the same standard in a single calendar year.
However, a single breach incident can result in violations of multiple standards. HIPAA also authorizes state attorneys general to file suit on behalf of their residents. Courts are able to award damages, costs and attorneys’ fees related to violations of HIPAA
in such cases. While HIPAA does not create a private right of action allowing individuals to sue us in civil court for violations of HIPAA, its standards have been used as the basis for duty of care in state civil suits such as those for negligence or recklessness in
the misuse or breach of PHI. In addition, HIPAA mandates that the Secretary of Health and Human Services, or HHS, conduct periodic compliance audits of HIPAA covered entities or business associates for compliance with the HIPAA Privacy and Security
Standards. It also tasks HHS with establishing a methodology whereby harmed individuals who were the victims of breaches of unsecured PHI may receive a percentage of the Civil Monetary Penalty fine paid by the violator. HIPAA further requires that
patients be notified of any unauthorized acquisition, access, use or disclosure of their unsecured PHI that compromises the privacy or security of such information, with certain exceptions related to unintentional or inadvertent use or disclosure by
employees or authorized individuals. HIPAA specifies that such notifications must be made “without unreasonable delay and in no case later than 60 calendar days after discovery of the breach.” If a breach affects 500 patients or more, it must be reported
to HHS without unreasonable delay, and HHS will post the name of the breaching entity on its public web site. Breaches affecting 500 patients or more in the same state or jurisdiction must also be reported to the local media. If a breach involves fewer than
500 people, the covered entity must record it in a log and notify HHS at least annually. Numerous other federal and state laws protect the confidentiality, privacy, availability, integrity and security of PII, including PHI. These laws in many cases are more
restrictive than, and may not be preempted by, the HIPAA rules and may be subject to varying interpretations by courts and government agencies, creating complex compliance issues for us and our clients and potentially exposing us to additional
expense, adverse publicity and liability. 35

RISK FACTORS
Our ability to make payments on our indebtedness will depend on our ability to generate cash in the future. Our ability to generate cash is subject to general economic and market conditions and financial, competitive, legislative, regulatory and other factors
that are beyond our control. Our business may not generate sufficient cash to fund our working capital requirements, capital expenditure, debt service and other liquidity needs, which could result in our inability to comply with financial and other covenants
contained in our debt agreements, our being unable to repay or pay interest on our indebtedness, and our inability to fund our other liquidity needs. If we are unable to service our debt obligations, fund our other liquidity needs and maintain compliance
with our financial and other covenants, we could be forced to curtail our operations, our creditors could accelerate our indebtedness and exercise other remedies and we could be required to pursue one or more alternative strategies, such as selling assets
or refinancing or restructuring our indebtedness; however, such alternatives may not be feasible or adequate.
Our potential for rapid growth and our entry into new markets make it difficult for us to evaluate our current and future business prospects, and we may be unable to effectively manage any growth associated with these new markets, which may increase the
risk of your investment and could harm our business, financial condition, results of operations and cash flow. Our entry into the rapidly growing health, wellness, construction and mentoring/life coaching market may place a significant strain on our resources
and increase demands on our executive management, personnel and systems, and our operational, administrative and financial resources may be inadequate. We may also not be able to effectively manage any expanded operations or achieve planned
growth on a timely or profitable basis, particularly if the number of customers using our technology significantly increases or their demands and needs change as our business expands. If we are unable to manage expanded operations effectively, we may
experience inefficiencies, the quality of our products and services could deteriorate, and our business and results of operations could be materially adversely affected. If we are unable to develop and maintain our brand and reputation for our service and
product offerings, our business and prospects could be materially harmed. Our business and prospects depend, in part, on developing and then maintaining and strengthening our brand and reputation in the markets we serve. If problems arise with our
products or services, our brand and reputation could be diminished. If we fail to develop, promote and maintain our brand and reputation successfully, our business and prospects could be materially harmed.
Any failure to protect our intellectual property rights could impair our ability to protect our technology and our brand. Our success depends in part on our ability to enforce our intellectual property and other proprietary rights. We rely upon a combination of
trademark and trade secret laws, as well as license and other contractual provisions, to protect our intellectual property and other proprietary rights. These laws, procedures and restrictions provide only limited protection and any of our intellectual property
rights may be challenged, invalidated, circumvented, infringed or misappropriated. To the extent that our intellectual property and other proprietary rights are not adequately protected, third parties may gain access to our proprietary information, develop
and market solutions similar to ours or use trademarks similar to ours, each of which could materially harm our business. The failure to adequately protect our intellectual property and other proprietary rights could have a material adverse effect on our
business, financial condition and results of operations The success of our wellness business is dependent upon quality medical services being rendered by our physicians. As the patient-physician relationship involves inherent trust and confidence, any
negative publicity, whether from civil litigation, allegations of criminal misconduct, or forfeiture of medical licenses, with respect to any of our physicians and/or our facilities could adversely affect our results of operations. If we fail to comply with government
laws and regulations it could have a materially adverse effect on our business. The healthcare industry is subject to extensive federal, state and local laws and regulations relating to licensure, conduct of operations, ownership of facilities, addition of facilities
and services, payment for services and prices for services that are extremely complex and for which, in many instances, the industry does not have the benefit of significant regulatory or judicial interpretation. We exercise care in structuring our arrangements
with physicians and other referral sources to comply in all material respects with applicable laws. We will also take such laws into account when planning future centers, marketing and other activities, and expect that our operations will be in compliance with
applicable law. The laws, rules and regulations described above are complex and subject to interpretation. In the event of a determination that we are in violation of such laws, rules or regulations, or if further changes in the regulatory framework occur, any
such determination or changes could have a material adverse effect on our business. There is no assurance that we will not be found in noncompliance in any particular situation.
We plan to rely on subcontractors to perform the actual construction work associated with our construction services, and in many cases, to select and obtain building materials. Despite detailed specifications and quality control procedures, in some cases,
subcontractors may use improper construction processes or defective materials. Defective products can result in the need to perform extensive repairs. The cost of complying with our warranty obligations may be significant if we are unable to recover the
cost of repairs from subcontractors, materials suppliers and insurers. We may also suffer damage to our reputation, and may be exposed to possible liability, if subcontractors fail to comply with applicable laws, including laws involving things that are not
within our control. Our acquisitions may expose us to unknown liabilities. Because we have acquired, and expect generally to acquire, all (or a majority of) the outstanding securities of certain of our acquisition targets, our investment in those companies are
or will be subject to all of their liabilities other than their respective debts which we paid or will pay at the time of the acquisitions. If there are unknown liabilities or other obligations, our business could be materially affected.
We are subject to the reporting requirements of federal securities laws, which are expensive and subject us to potential liability. We are a public reporting company in the United States and, accordingly, subject to the information and reporting requirements
of the Exchange Act and other federal securities laws, and the compliance obligations of the Sarbanes-Oxley Act. The costs of preparing and filing annual and quarterly reports, proxy statements and other information with the SEC and furnishing audited
reports to stockholders causes our expenses to be higher than they would be if we remained a privately-held company. We could also be subject to sanctions or deregistration if we fail to keep up with or run afoul of our reporting obligations. Our
compliance with the Sarbanes-Oxley Act and SEC rules concerning internal controls is time consuming, difficult and costly. Because we are a reporting company with the SEC, we must comply with Sarbanes-Oxley Act and SEC rules concerning internal
controls. It is time consuming, difficult and costly for us to develop and implement the internal controls and reporting procedures required by the Sarbanes-Oxley Act. In order to expand our operations, we will need to hire additional financial reporting,
internal control, and other finance staff in order to develop and implement appropriate internal controls and reporting procedures. Shareholders who hold unregistered shares of our common stock will be subject to resale restrictions pursuant to Rule 144, if
and when available, due to the fact that we are deemed to be a former “shell company”. Pursuant to Rule 144 of the Securities Act of 1933, as amended (“Rule 144”), a “shell company” is defined as a company that has no or nominal operations; and, either
no or nominal assets; assets consisting solely of cash and cash equivalents; or assets consisting of any amount of cash and cash equivalents and nominal other assets. While we do not believe that we are currently a “shell company”, we were previously a
“shell company” and as such are deemed to be a former “shell company” pursuant to Rule 144, and as such, sales of our securities pursuant to Rule 144 may not be able to be made if we are not subject to Section 13 or 15(d) of the Exchange Act, and have
filed all of our required periodic reports for at least the previous one year period prior to any sale pursuant to Rule 144; and a period of at least twelve months has elapsed from the date “Form 10 information” has been filed with the Commission reflecting
the Company’s status as a non-”shell company” (which Form 10 information was filed by the Company in August 2019). Although to date we have complied with the requirement of Rule 144 as related to “shell companies”, our status as a former “shell
company” could prevent us from raising additional funds, engaging consultants, and using our securities to pay for any acquisitions in the future (although none are currently planned). If we are unable to adequately protect our intellectual property rights our
business is likely to be adversely affected.
36

AMIH
Thank You
Contact Information
Mr. Jacob Cohen
Chief Executive Officer, AMIH
7950 Legacy Drive, Suite 400
Plano, TX 75024
Office: (469) 838-6468 | Cell: (214) 938-1217
Emails: jacob@amihcorp.com
Mr. Alejandro Rodriguez
Chief Strategy Officer, AMIH
7950 Legacy Drive, Suite 400
Plano, TX 75024
Office: (469) 838-6468 | Cell: (972) 467-6784
Emails: alejandro@epiqmd.com

American International Holdings Deck March 2022

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to American International Holdings Deck March 2022

Similar to American International Holdings Deck March 2022 (20)

More from RedChip Companies, Inc.

More from RedChip Companies, Inc. (20)

Recently uploaded

Recently uploaded (20)

American International Holdings Deck March 2022